Key result
Patients with digoxin toxicity had a higher mean serum digoxin concentration than those with subtherapeutic or eutherapeutic levels.
Why the study?
Does serum digoxin level monitoring aid in the diagnosis of chronic digitalis toxicity in cardiac patients?
Cross-Sectional
Does serum digoxin level monitoring aid in the diagnosis of chronic digitalis toxicity in cardiac patients?
Regular monitoring of serum digoxin levels is clinically valuable for verifying therapeutic effects and enabling the early diagnosis of chronic digitalis toxicity.
Answers are grounded in this paper and cite their sources.
Higher levels associated with toxicity; cross-sectional data leave monitoring's diagnostic value open for prospective study.
Digitalis toxicity is a complication of the digitalis therapy. It could occur also due to the patient taking in a much larger dose of the drug than prescribed. The general symptoms of Digitalis toxicity are typically gastro-intestinal, neurologic and non-specific cardiac type manifestations that are strikingly similar to the clinical picture of primary Congestive Heart Failure (CHF) making a diagnosis of chronic digitalis toxicity in particular relatively difficult. Serum digoxin measurement is today becoming a crucial subject of concern because of the narrow therapeutic window of digoxin besides increasing mortality and morbidity due to its intoxication. The present work is focused on evaluating the clinical value of Serum Digoxin Concentrations (SDCs) in relation to appropriate assessment of chronic digitalis toxicity in cardiac patients. The current study was conducted in the form of a cross-sectional Electronic Medical Record (EMR) review study of patients presently on continuous prescriptions for digoxin with there being zero gaps in therapy for at least 10 days prior to SDC result entered into the Online Analytical Toxicology Request Result (OTARR). There was also a complete clinical examination report as well as a review of the results of serum potassium concentration, liver and kidney functions. Patients with digoxin toxicity (11.9%) had a significantly higher mean SDC (2.75 ± 1.2) than those with subtherapeutic (0.67 ± 0.17 ng/mL) or eutherapeutic SDC (1.19 ± 0.26 ng/mL) (p value ≤ 0.05). About 12% of the total cases showed an abnormal serum potassium concentration of electrolyte fluctuations. From this, one can conclude that a regular monitoring of serum digoxin level would be seen as mandatory for the verification of digoxin’s therapeutic effects and then the subsequent prevention and early diagnosis of chronic toxicity.
No takes yet. Share an insight, caveat, or question.
Ahmed Refat Ragab (2012) conducted a cross-sectional in Chronic digitalis toxicity. Digoxin toxicity vs. Subtherapeutic or eutherapeutic digoxin levels was evaluated on Mean Serum Digoxin Concentration (SDC) (p=≤ 0.05). Patients with digoxin toxicity had a higher mean serum digoxin concentration than those with subtherapeutic or eutherapeutic levels.
Synapse has enriched 10 related papers. Consider them for comparative context: